As the world continued to battle the COVID-19 pandemic, Research Partnership held a strong position in 24th place among the Top 100 individual agencies, with a turnover of £45.136m. This represented a 12% increase on the previous year's turnover, against an industry average of 6.4%. In addition, Research Partnership was ranked 27th in the top 50 consolidated business league table.
Co-CEO Mark Jeffery commented, “We are delighted to see that Research Partnership continues to hold a strong position in the MRS rankings, as well as a steady rise in turnover every year. We’ve achieved good growth in both our custom market research and market access services, as well as our syndicated business, which put us in a strong position for our acquisition by Ashfield in February 2022. We are now part of Inizio, a strategic partner for health and life sciences that unites Ashfield and Huntsworth’s full suite of advisory, medical, marketing, communications, and patient and stakeholder engagement services. As a company within the Inizio Advisory business unit, we are now excellently placed to offer our clients in global healthcare a broader breadth of services and insights.”